Hepadnaviral X protein: Review of recent progress (original) (raw)
References
Antunovic J, Lemieux N, Cromlish JA. The 17 kDa HBx protein encoded by hepatitis B virus interacts with the activation domains of Oct-1, and functions as a coactivator in the activation and repression of a human U6 promoter. Cell Mol Biol Res 39:463–482;1993. Google Scholar
Arii M, Takada S, Koike K. Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene 7:397–403;1992. Google Scholar
Aufiero B, Schneider RJ. The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. Embo J 9:497–504;1990. Google Scholar
Balsano C, Avantaggiati ML, Natoli G, De Me, Will H, Perricaudet M, Levrero M. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. Biochem Biophys Res Commun 176:985–992;1991. Google Scholar
Balsano C, Billet O, Bennoun M, Cavard C, Zider A, Grimber G, Natoli G, Briand P, Levrero M. Hepatitis B virus X gene product acts as a transactivator in vivo. J Hepatol 21:103–109;1994. Google Scholar
Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 91:10350–10354;1994. Google Scholar
Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci USA (in press); 1995.
Blum HE, Zhang ZS, Galun E, von Weiszäcker WF, Garner B, Liang TJ, Wands JR. Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol 66:1223–1227;1992. Google Scholar
Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429–431;1991. Google Scholar
Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH. The wood-chuck hepatitis virus X gene is important for establishment of virus infection in wood-chucks. J Virol 67:1218–1226:1993. Google Scholar
Cheong JH, Yi M, Lin Y, Murakami S. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J 14:142–150;1995. Google Scholar
Colgrove R, Simon G, Ganem D. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol 63:4019–4026;1989. Google Scholar
Cross JC, Wen P, Rutter WJ. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci USA 90:8078–8082;1193. Google Scholar
De Medina T, Shaul Y. Functional and structural similarity between the X protein of hepatitis B virus and nucleoside diphosphate kinases. FEBS Lett 351:423–426;1994. Google Scholar
De Medina T, Haviv I, Noiman S, Shaul Y. The X protein of hepatitis B virus has a ribo/deoxy ATPase activity. Virology 202:401–407;1994. Google Scholar
Doria M, Klein N, Lucito R, Schneider RJ. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J (in press); 1995.
Faktor O, Shaul Y. The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax. Oncogene 5:867–872;1990. Google Scholar
Feitelson MA, Zhu M, Duan LX, London WT. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109–1117;1993. Google Scholar
Fischer M, Runkel L, Schaller H. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit. Virus Genes 10:99–102;1995. Google Scholar
Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Ann Rev Biochem 56:651–693;1987. Google Scholar
Gao WY, Cara A, Gallo RC, Lori F. Low levels of deoxynucleotides in peripheral blood lymphocytes: A strategy to inhibit human immunodeficiency virus type 1 replication. Proc Natl Acad Sci USA 90:8925–8928;1993. Google Scholar
Gordon C, McGurk G, Dillon P, Rosen C, Hastie ND. Defective mitosis due to a mutation in the gene for a fission yeast 26S protease subunit. Nature 366:355–357;1993. Google Scholar
Goulaoui H, Subra F, Mouscaded JF, Carteau S, Auclair C. Exogenous nucleosides promote the completion of MoMLV DNA synthesis in G0-arrested Balb c/3T3 fibroblasts. Virology 200:87–97;1994. Google Scholar
Guo WT, Bell KD, Ou JH. Characterization of the hepatitis B virus EnhI enhancer and X promoter complex. J Virol 65:6686–6692;1991. Google Scholar
Guo WT, Wang J, Tam G, Yen TS, Ou JS. Leaky transcription termination produces larger and smaller than genome size hepatitis B virus X gene transcripts. Virology 181:630–636;1991. Google Scholar
Haruna Y, Hayashi N, Katayama K, Yuki N, Kasahara A, Sasaki Y, Fusamoto H, Kamada T. Expression of X protein and hepatitis B virus replication in chronic hepatitis. Hepatology 13:417–421;1991. Google Scholar
Hess J, Stemler M, Will H, Schroder CH, Kuhn J, Braun R. Frequent detection of antibodies to hepatitis B virus x-protein in acute, chronic and resolved infections. Med Microbiol Immunol (Berl) 177:195–205;1988. Google Scholar
Hohne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 9:1137–1145;1990. Google Scholar
Hollinger FB. Hepatitis B virus. In: Fields BN, Knipe DM eds. Virology. New York, Raven Press, 2171–2238;1990. Google Scholar
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427–428;1991. Google Scholar
Ichimura H, Levy JA. Polymerase substrate depletion: A novel strategy for inhibiting the replication of the human immunodeficiency virus. Virology 211:554–560;1995. Google Scholar
Kanno T, Brown K, Siebenlist U. Evidence in support of a role for human T-cell leukemia virus type I Tax in activating NF-kappa B via stimulation of signaling pathways. J Biol Chem 270:11745–11748;1995. Google Scholar
Kay A, Dupont de Dinechin S, Vitvitski TL, Mandart E, Shamoon BM, Galibert F. Recognition of the N-terminal, C-terminal, and interior portions of HBx by sera from patients with hepatitis B. J Med Virol 33:228–235;1991. Google Scholar
Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361:742–745;1993. Google Scholar
Kido H, Fukutomi A, Katunuma N. A novel membrane-bound serine esterase in human T4+ lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1: Purification and characterization. J Biol Chem 265:21979–21985;1990. Google Scholar
Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317–320;1991. Google Scholar
Kim YH, Kang SK, Lee YI. Functional analysis of hepatitis B virus transactivator X: Implication of the leucine zipper-like region and C-terminal seven conserved amino acids in functional regions. Biochem Biophys Res Commun 197:894–903;1993. Google Scholar
Koike K, Moriya K, Yotsuyanagi H, Iino S, Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest 94:44–49;1994. Google Scholar
Kwee L, Lucito R, Aufiero B, Schneider RJ. Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J Virol 66:4382–4389;1992. Google Scholar
Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SL, Butel JS. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 64:5939–5947;1990. Google Scholar
Lee TH, Elledge SJ, Butel JS. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol 69:1107–1114;1995. Google Scholar
Levrero M, Jean JO, Balsano C, Will H, Perricaudet M. Hepatitis B virus (HBV) X gene expression in human cells and anti-HBx antibodies detection in chronic HBV infection. Virology 174:299–304;1990. Google Scholar
Levrero M, Stemler M, Pasquinelli C, Alberti A, Jean JO, Franco A, Balsano C, Diop D, Brechot C, Melegari M, et al. Significance of anti-HBx antibodies in hepatitis B virus infection. Hepatology 13:143–149;1991. Google Scholar
Liu F, Green MR. Promoter targeting by adenovirus Ela through interaction with different cellular DNA-binding domains. Nature 368:520–525;1994. Google Scholar
Lucito R, Schneider RJ. Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol 66:983–991;1992. Google Scholar
Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252:842–844;1991. Google Scholar
Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 266:13759–13763;1991. Google Scholar
Miller RH, Robinson WS. Common evolutionary origin of hepatitis B virus and retroviruses. Proc Natl Acad Sci USA 83:2531–2535;1986. Google Scholar
Murakami S, Cheong JH, Kaneko S. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem 269:15118–15123;1994. Google Scholar
Murakami S, Cheong J, Ohno S, Matsushima K, Kaneko S. Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. Virology 199:243–246;1994. Google Scholar
Nagashima H, Imai M, Iwakura Y. Aberrant tissue specific expression of the transgene in transgenic mice that carry the hepatitis B virus genome defective in the X gene. Arch Virol 132:381–397;1993. Google Scholar
Nakamura I, Koike K. Identification of a binding protein to the X gene promoter region of hepatitis B virus. Virology 191:533–540;1992. Google Scholar
Nakatake H, Chisaka O, Yamamoto S, Matsubara K, Koshy R. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication. Virology 195:305–314;1993. Google Scholar
Natoli G, Avantaggiati ML, Chirillo P, Puri PL, Ianni A, Balsano C, Levrero M. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 9:2837–2843;1994. Google Scholar
Natoli G, Avantaggiati ML, Chirillo P, Costanzo A, Artini M, Balsano C, Levrero M. Induction of the DNA-binding activity of c-_jun/c_-fos heterodimers by the hepatitis B virus transactivator pX. Mol Cell Biol 14:989–998;1994. Google Scholar
Papa FR, Hochstrasser M. The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene. Nature 366:313–319;1993. Google Scholar
Pfaff E, Salfeld J, Gmelin K, Schaller H, Theilmann L. Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology 158:456–460;1987. Google Scholar
Puisieux A, Ji J, Guillot C, Legros Y, Soussi T, Isselbacher K, Ozturk M. p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus. Proc Natl Acad Sci USA 92:1342–1346;1995. Google Scholar
Qadri I, Maguire HF, Siddiqui A. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci USA 92:1003–1007;1995. Google Scholar
Renner M, Haniel A, Buergelt E, Hofschneider PH, Koch W. Transactivating function and expression of the x gene of hepatitis B virus. J Hepatol 23:53–65;1995. Google Scholar
Rossner MT. Review: Hepatitis B virus X-gene product: A promiscuous transcriptional activator. J Med Virol 36:101–117;1992. Google Scholar
Rothnie HM, Chapdelaine Y, Hohn T. Pararetroviruses and retroviruses: a comparative review of viral structure and gene expression strategies. Adv Virus Res 44:1–67;1994. Google Scholar
Runkel L, Fischer M, Schaller H. Two-codon insertion mutations of the HBx define two separate regions necessary for its trans-activation function. Virology 197:529–536;1993. Google Scholar
Schek N, Bartenschlager R, Kuhn C, Schaller H. Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene 6:1735–1744;1991. Google Scholar
Scorsone KA, Zhou YZ, Butel JS, Slagle BL. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 52:1635–1638;1992. Google Scholar
Semmes OJ, Jeang KT. Definition of a minimal activation domain in human T-cell leukemia virus type I Tax. J Virol 69:1827–1833;1995. Google Scholar
Seroz T, Hwang JR, Moncollin V, Egly JM. TFIIH: A link between transcription, DNA repair and cell cycle regulation. Curr Opin Genet Dev 5:217–221;1995. Google Scholar
Seto E, Yen TS, Peterlin BM, Ou JH. Transactivation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci USA 85:8286–8290;1988. Google Scholar
Seto E, Zhou DX, Peterlin BM, Yen TS. Transactivation by the hepatitis B virus X protein shows cell-type specificity. Virology 173:764–766;1989. Google Scholar
Seto E, Mitchell PJ, Yen TS. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344:72–74;1990. Google Scholar
Seto E, Yen TS. Mutual functional antagonism of the simian virus 40 T antigen and the hepatitis B virus trans activator. J Virol 65:2351–2356;1991. Google Scholar
Shibuya H, Irie K, Ninomiya TJ, Goebl M, Taniguchi, Matsumoto K. New human gene encoding a positive modulator of HIV Tat-mediated transactivation. Nature 357:700–702;1992. Google Scholar
Siddiqui A, Jameel S, Mapoles J. Expression of the hepatitis B virus X gene in mammalian cells. Proc Natl Acad Sci USA 84:2513–2517;1987. Google Scholar
Spandau DF, Lee CH. Trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol 62:427–434;1988. Google Scholar
Sugata F, Chen HS, Kaneko S, Purcell RH, Miller RH. Analysis of the X gene promoter of woodchuck hepatitis virus. Virology 205:314–320;1994. Google Scholar
Takada S, Kido H, Fukutomi A, Mori T, Koike K. Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor. Oncogene 9:341–348;1994. Google Scholar
Treinin M, Laub O. Identification of a promoter element located upstream from the hepatitis B virus X gene. Mol Cell Biol 7:545–548;1987. Google Scholar
Truant R, Antunovic J, Greenblatt J, Prives C, Cromlish JA. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol 69:1851–1859;1995. Google Scholar
Twu JS, Rosen CA, Haseltine WA, Robinson WS. Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X. J Virol 63:2857–2860;1989. Google Scholar
Unger T, Shaul Y. The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. EMBO J 9:1889–1895;1990. Google Scholar
Wagner S, Green MR. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262:395–399;1993. Google Scholar
Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 91:2230–2234;1994. Google Scholar
Wild CP, Jansen LA, Cova L, Montesano R. Molecular dosimetry of aflatoxin exposure: Contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus. Environ Health Perspect 99:115–122;1993. Google Scholar
Williams JS, Andrisani OM. The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proc Natl Acad Sci USA 92:3819–3823;1995. Google Scholar
Wu JY, Zhou ZY, Judd A, Cartwright CA, Robinson WS. The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase [published erratum appears in Cell 75:826;1993]. Cell 63:687–695;1990. Google Scholar
Yen TSB. Regulation of hepatitis B virus gene expression. Seminars Virol 4:33–42;1993. Google Scholar
Zentgraf H, Herrmann G, Klein R, Schranz P, Loncarevic I, Herrmann D, Hubner K, Schroder CH. Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in_Escherichia coli_: Detection of reactive antigen in liver cell carcinoma and chronic hepatitis. Oncology 47:143–148;1990. Google Scholar
Zheng YW, Riegler J, Wu J, Yen TS. Novel short transcripts of hepatitis B virus X gene derived from intragenic promoter. J Biol Chem 269:22593–22598;1994. Google Scholar
Zhou DX, Taraboulos A, Ou JH, Yen TS. Activation of class I major histocompatibility complex gene expression by hepatitis B virus. J Virol 64:4025–4028;1990. Google Scholar
Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68:2026–2030;1994. Google Scholar